Eli Lilly Stock Jumps as Weight-Loss Drugs Fuel Sales 0 08.08.2024 16:26 The Wall Street Journal The drugmaker reported strong second-quarter earnings and raised its outlook for the year amid the strong performance of Mounjaro and Zepbound. Shares rose 10% premarket. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
